Abstract
Nadolol and propranolol are beta-blockers used to prevent the onset of migraines. Two simple and rapid High Performance Liquid Chromatographic (HPLC) methods with ultraviolet detection were evaluated in order to establish their efficacy for detecting nadolol and propranolol hydrochloride in samples obtained from in vitro transdermal absorption studies. Both methods were validated for specificity, linearity, precision, accuracy, limit of detection, limit of quantification and robustness. Moreover, the stability of both drugs in a buffered solution was assessed. Separation was carried out on a 250 mm Kromasil® C18 column at room temperature. When nadolol was analysed, the detector response at 269 nm was found to be linear in a concentration range of 0.17 to 167 μM. In the case of propranolol hydrochloride, a fixed wavelength of 291 nm for quantification corresponded with calibration lines in the range of 0.11 to 113 μM. The limits of detection (LOD) and quantification (LOQ) were 0.058 and 0.038 μM and 0.171 and 0.115 μM for nadolol and propranolol hydrochloride, respectively. The maximum relative error and relative standard deviation detected were 5.19% and 6.08% respectively for nadolol and 3.57% and 6.44% respectively for propranolol hydrochloride. The results of robustness were highly satisfactory.
Keywords: Nadolol, Propranolol hydrochloride, Reverse-phase chromatography, HPLC-UV detection, Transdermal diffusion, Specificity, Linearity, Precision, Accuracy, Limit of detection, Limit of quantification, Robustness, Validation, beta-blockers
Current Pharmaceutical Analysis
Title: Validation of Two High-Performance Liquid Chromatographic Methods for the Analysis of Nadolol and Propranolol Hydrochloride Following In Vitro Transdermal Diffusion Studies
Volume: 7 Issue: 2
Author(s): M. A. Calatayud-Pascual, C. Balaguer-Fernandez, C. E. Serna-Jimenez, S. del Rio-Sancho, A. Femenia-Font, A. Lopez-Castellano and V. Merino
Affiliation:
Keywords: Nadolol, Propranolol hydrochloride, Reverse-phase chromatography, HPLC-UV detection, Transdermal diffusion, Specificity, Linearity, Precision, Accuracy, Limit of detection, Limit of quantification, Robustness, Validation, beta-blockers
Abstract: Nadolol and propranolol are beta-blockers used to prevent the onset of migraines. Two simple and rapid High Performance Liquid Chromatographic (HPLC) methods with ultraviolet detection were evaluated in order to establish their efficacy for detecting nadolol and propranolol hydrochloride in samples obtained from in vitro transdermal absorption studies. Both methods were validated for specificity, linearity, precision, accuracy, limit of detection, limit of quantification and robustness. Moreover, the stability of both drugs in a buffered solution was assessed. Separation was carried out on a 250 mm Kromasil® C18 column at room temperature. When nadolol was analysed, the detector response at 269 nm was found to be linear in a concentration range of 0.17 to 167 μM. In the case of propranolol hydrochloride, a fixed wavelength of 291 nm for quantification corresponded with calibration lines in the range of 0.11 to 113 μM. The limits of detection (LOD) and quantification (LOQ) were 0.058 and 0.038 μM and 0.171 and 0.115 μM for nadolol and propranolol hydrochloride, respectively. The maximum relative error and relative standard deviation detected were 5.19% and 6.08% respectively for nadolol and 3.57% and 6.44% respectively for propranolol hydrochloride. The results of robustness were highly satisfactory.
Export Options
About this article
Cite this article as:
A. Calatayud-Pascual M., Balaguer-Fernandez C., E. Serna-Jimenez C., del Rio-Sancho S., Femenia-Font A., Lopez-Castellano A. and Merino V., Validation of Two High-Performance Liquid Chromatographic Methods for the Analysis of Nadolol and Propranolol Hydrochloride Following In Vitro Transdermal Diffusion Studies, Current Pharmaceutical Analysis 2011; 7 (2) . https://dx.doi.org/10.2174/157341211795684862
DOI https://dx.doi.org/10.2174/157341211795684862 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural or Plant Products for the Treatment of Neurological Disorders: Current Knowledge
Current Drug Metabolism The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias
Current Neuropharmacology Clinical, Genetic, and Neuroimaging Features of Early Onset Alzheimer Disease: The Challenges of Diagnosis and Treatment
Current Alzheimer Research Antidepressants: Current Strategies and Future Opportunities
Current Pharmaceutical Design Antihistamine Use in Dermatologic Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Activity Pacing Education for People with Osteoarthritis: A Systematic Review of the Current Evidence-base
Current Rheumatology Reviews Convection Enhanced Delivery of Macromolecules for Brain Tumors
Current Drug Discovery Technologies Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain
Current Neuropharmacology Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Effect of Proton Pump Inhibitors on the Human Microbiota
Current Drug Metabolism Therapeutic Potential of 5-HT7 Receptors in Mood Disorders
Current Drug Targets Anti-VEGF Strategies – from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer
Current Pharmaceutical Design Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design The Psychopharmacology of European Herbs with Cognition-Enhancing Properties
Current Pharmaceutical Design Fast Disintegrating Film Approach for the Oral Delivery of Zolmitriptan: Formulation, <i>In Vitro</i> and <i>In Vivo</i> Evaluation
Drug Delivery Letters New Strategies for Managing Anemia of Chronic Kidney Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry COVID-19: Challenges and its Technological Solutions using IoT
Current Medical Imaging Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder
Current Neuropharmacology Viral Encephalitis: Current Treatments and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?
CNS & Neurological Disorders - Drug Targets